Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Hepatitis Monthly
  4. Articles

  5. Lobaplatin Inhibits the Proliferation of Hepatollular Carcinoma Through P53 Apoptosis Axis
  6. Crossref

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Home
Current IssueAccepted ManuscriptsAll IssuesIn Press ArticlesSearch
Instructions
Journal InformationBoards and committeesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Crossref


1. Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis

- Chaobin He

- Yu Zhang

- Xiaojun Lin

2. p53 gene therapy‐based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study

- Ai Shen

- Shihong Liu

- Weiqian Yu

- Hejun Deng

- Qingdong Li

3. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study

- Chao-Bin He

- Xiang-Ming Lao

- Xiao-Jun Lin

HomeInstructionsAPC

Articles

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press Articles
  • Search

About Journal

  • Journal Information
  • Boards and committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.